baltimore conference logo
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Sequencing Sorafenib and Lenvatinib in Thyroid Cancer

September 27, 2014
Marcia S. Brose, MD, PhD

Special Reports, Head and Neck Cancers (Issue 2), Volume 2, Issue 1

Marcia S. Brose, MD, PhD, discusses using both sorafenib and lenvatinib as treatment options for thyroid cancer.